CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

PR Newswire Biotech
Original article

Karyopharm Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Neutral
AI Analysis

Summary

Karyopharm Therapeutics granted 333 RSUs to a newly-hired employee under NASDAQ Listing Rule 5635(c)(4) as an inducement grant.

Importance:1/10
Sentiment:
0.00
inducement grantequity compensationNASDAQ listing ruleroutine announcement
Related Companies

Read the original article

Published by PR Newswire Biotech on October 1, 2026 8:05 PM

Read Original